Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
Updated Guidance on the Use of Multidose Vials (PIDAC IPC Guidance)
This is not placebo: GHK-Cu upregulates glycosaminoglycan synthesis, including hyaluronic acid and dermatan sulfate, which directly increase skin hydration at the dermal level
Detection times refer to the amount of time it takes for the body to get rid of the drugs byproducts
$119.73 Original price was: $119.73.$95.78Current price is: $95.78
US$ 24.05
US$ 23.89
US$ 27.74
US$ 25.32
